Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
IMNN-001 by Imunon for Epithelial Ovarian Cancer: Likelihood of Approval
IMNN-001 is under clinical development by Imunon and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData, Phase...
Data Insights
FPA-150 by Five Prime Therapeutics for Epithelial Ovarian Cancer: Likelihood of Approval
FPA-150 is under clinical development by Five Prime Therapeutics and currently in Phase I for Epithelial Ovarian Cancer. According to...